» Articles » PMID: 34721413

Elevated Peripheral T Helper Cells Are Associated With Atrial Fibrillation in Patients With Rheumatoid Arthritis

Overview
Journal Front Immunol
Date 2021 Nov 1
PMID 34721413
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with rheumatoid arthritis (RA) have a significantly high risk of atrial fibrillation (AF). This study aimed to compare the absolute and relative changes in peripheral T cells in patients with RA who were also affected with and without AF. To help make an early diagnosis and prevent the initiation and progression of AF, the changes in the lymphocyte subsets were assessed in RA patients with and without AF. A propensity score matching (PSM) system (1:3) was used to perform a matched case-control study with 40 RA-AF cases and 120 RA controls. Changes in the erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), anti-citrullinated peptide antibody (ACPA), and rheumatoid factor (RF) were examined. The percentage and absolute number of T, B, natural killer (NK), T helper (Th)1, Th2, Th17, and T-regulatory (Treg) cells in the peripheral blood of patients with and without RA-AF were determined using flow cytometry. Univariate and multivariate analyses were performed to determine the association between peripheral lymphocytes and RA-AF. Demographic data, ESR, CRP, ACPA, and the percentage, as well as the absolute value of B, NK, Th2, and Treg cells, showed no significant differences between the propensity score-matched groups of RA and RA-AF. Meanwhile, the absolute number and percentage of Th1 cells, the absolute number of Th17 cells, the ratio of Th1/Treg, Th17/Treg, and RF were significantly higher in patients with RA-AF than those in the control groups (P < 0.05). Univariate and multivariate logistic regression analyses also revealed that the percentage of Th1 cells, the absolute number of Th17 cells, and the ratio of Th1/Treg were associated with a significantly higher risk of AF. This PSM study demonstrated that the incidence of AF was higher in RA patients with Th cell immunological derangements.

Citing Articles

Id2 exacerbates the development of rheumatoid arthritis by increasing IFN-γ production in CD4 T cells.

Sun H, Miao J, Zhang K, Zhang P, Shen H, Wang J Clin Transl Med. 2025; 15(3):e70242.

PMID: 40051059 PMC: 11885165. DOI: 10.1002/ctm2.70242.


Single-cell sequencing of immune cells from the coronary sinus reveals immune mechanisms of the progression of persistent atrial fibrillation.

Chen C, Pang Y, Cheng K, Gao X, Ling Y, Xu Y iScience. 2024; 27(6):110127.

PMID: 38966571 PMC: 11223078. DOI: 10.1016/j.isci.2024.110127.


The association between antiphospholipid syndrome and atrial fibrillation: a single center retrospective case-control study.

Zhou Z, Liu Y PeerJ. 2024; 12:e17617.

PMID: 38948200 PMC: 11214423. DOI: 10.7717/peerj.17617.


Association between rheumatoid arthritis and atrial fibrillation: A systematic review and meta-analysis.

Jaiswal V, Roy P, Ang S, Shama N, Deb N, Mohamed Taha A J Arrhythm. 2024; 40(2):203-213.

PMID: 38586849 PMC: 10995606. DOI: 10.1002/joa3.12995.


The balance between CD4+ T helper 17 and T-cell immunoglobulin and mucin domain 3 is involved in the pathogenesis and development of atrial fibrillation.

Dai W, Zhang J, Wang Y, Zhou J, Dai Q, Lv J Afr Health Sci. 2024; 23(3):607-615.

PMID: 38357157 PMC: 10862566. DOI: 10.4314/ahs.v23i3.71.


References
1.
Sulzgruber P, Koller L, Winter M, Richter B, Blum S, Korpak M . The impact of CD4CD28 T-lymphocytes on atrial fibrillation and mortality in patients with chronic heart failure. Thromb Haemost. 2016; 117(2):349-356. DOI: 10.1160/TH16-07-0531. View

2.
Liu Y, Zhu H, Su Z, Sun C, Yin J, Yuan H . IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCβ/Erk1/2/NF-κB-dependent signaling pathway. Int Immunol. 2012; 24(10):605-12. DOI: 10.1093/intimm/dxs056. View

3.
Capuron L, Geisler S, Kurz K, Leblhuber F, Sperner-Unterweger B, Fuchs D . Activated immune system and inflammation in healthy ageing: relevance for tryptophan and neopterin metabolism. Curr Pharm Des. 2014; 20(38):6048-57. DOI: 10.2174/1381612820666140317110217. View

4.
Maradit-Kremers H, Crowson C, Nicola P, Ballman K, Roger V, Jacobsen S . Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005; 52(2):402-11. DOI: 10.1002/art.20853. View

5.
Furst D, Emery P . Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets. Rheumatology (Oxford). 2014; 53(9):1560-9. PMC: 4135582. DOI: 10.1093/rheumatology/ket414. View